These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 18347448

  • 1. Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension.
    White WB.
    Blood Press Monit; 2008 Apr; 13(2):123-9. PubMed ID: 18347448
    [Abstract] [Full Text] [Related]

  • 2. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME, Epstein BJ.
    J Cardiovasc Nurs; 2009 Apr; 24(5):380-9. PubMed ID: 19707098
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The future of antihypertensive treatment.
    Israili ZH, Hernández-Hernández R, Valasco M.
    Am J Ther; 2007 Apr; 14(2):121-34. PubMed ID: 17414579
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus.
    Reboldi G, Gentile G, Angeli F, Verdecchia P.
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1349-61. PubMed ID: 19900018
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
    Waeber B.
    J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH, Lyoussi B, Hernández-Hernández R, Velasco M.
    Am J Ther; 2007 May; 14(4):386-402. PubMed ID: 17667215
    [Abstract] [Full Text] [Related]

  • 11. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB.
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Management of cardiovascular risk with RAS inhibitor/CCB combination therapy.
    Dahlöf B.
    J Hum Hypertens; 2009 Feb; 23(2):77-85. PubMed ID: 18685606
    [Abstract] [Full Text] [Related]

  • 14. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K, Miller NH.
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
    Bramlage P.
    Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001
    [Abstract] [Full Text] [Related]

  • 19. Recent update in the management of hypertension.
    Lim S.
    Acta Med Indones; 2007 Aug; 39(4):186-91. PubMed ID: 18380058
    [Abstract] [Full Text] [Related]

  • 20. Olmesartan/Amlodipine: combination therapy for the treatment of hypertension [corrected].
    Pimenta E.
    Adv Ther; 2009 Jan; 26(1):1-11. PubMed ID: 19129998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.